The pandemic might have had a beneficial effect on fundraising by “highlighting how impactful healthcare innovation can be,” Sagard's David MacNaughtan told Buyouts.
KKR’s Alisa Wood: PE isn’t worth it if you can’t access top GPs
22 hours ago · 3 mins read
New Hunter Point Capital COO and president maps out strategy
23 September 2026 · 5 mins read
Advent International targets $3bn for debut mid-market fund
22 September 2026 · 2 mins read
Off-duty: Abry’s CJ Brucato on football, 'Stairway to Heaven' and Sunday Italian gravy
21 September 2026 · 7 mins read
Why it pays to play ball during LP-leds
18 September 2026 · 2 mins read
Lower-mid market Siguler Guff leverages exits to its biggest fundraise
18 September 2026 · 3 mins read
Warburg Pincus on the cusp of wrapping up 15th flagship growth fund
10 September 2026 · 3 mins read
